AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Flexibility keeps budgets resilient. Explore techniques to flex categories, set automatic rebalances, and protect core priorities.
18,624 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
When a tech titan backs a biotech startup, investors take note. This article digs into whether Jeff Bezos backed Grai...
In 2026, four Dividend Kings are outperforming the S&P 500 as investors pivot to cash-flow creators. The move signals...
Morgan Stanley reveals a sharper cost curve for AI data centers, suggesting only a few players can fund the next wave...
A timely look at how independent journalism survives in 2026, focusing on Amy Goodman and the economics of free‑press...
Steak ’n Shake reports a 16% July lift in U.S. same-store sales and attributes it to Bitcoin adoption, but the absenc...
Bitcoin slides toward $63,000 as a broad market pullback and a record-long negative Coinbase premium weigh on prices....
A niche bond ETF focused on mid-tier CLO tranches is drawing buyers as rate expectations stay elevated. The fund aims...
Geopolitical headlines push risk-off moves while Hut 8 leads a tech rally on AI data center news. This guide breaks d...
Disney trades at a notably lower multiple than Netflix, but the reasons go beyond simple numbers. This guide breaks d...
Founders Fund's ETHZilla fully liquidates its ether holdings, selling $74.5 million as the crypto market slides. The ...
As markets swing into February 2026, a core group of performing cash stocks on Cash App are leading gains. This repor...